1. Home
  2. BCAB vs MOB Comparison

BCAB vs MOB Comparison

Compare BCAB & MOB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCAB
  • MOB
  • Stock Information
  • Founded
  • BCAB 2007
  • MOB 2008
  • Country
  • BCAB United States
  • MOB Israel
  • Employees
  • BCAB N/A
  • MOB N/A
  • Industry
  • BCAB Medicinal Chemicals and Botanical Products
  • MOB Real Estate Investment Trusts
  • Sector
  • BCAB Health Care
  • MOB Real Estate
  • Exchange
  • BCAB Nasdaq
  • MOB Nasdaq
  • Market Cap
  • BCAB 22.3M
  • MOB 21.1M
  • IPO Year
  • BCAB 2020
  • MOB 2022
  • Fundamental
  • Price
  • BCAB $0.38
  • MOB $2.94
  • Analyst Decision
  • BCAB Buy
  • MOB
  • Analyst Count
  • BCAB 2
  • MOB 0
  • Target Price
  • BCAB $1.00
  • MOB N/A
  • AVG Volume (30 Days)
  • BCAB 507.7K
  • MOB 327.8K
  • Earning Date
  • BCAB 08-07-2025
  • MOB 03-27-2025
  • Dividend Yield
  • BCAB N/A
  • MOB N/A
  • EPS Growth
  • BCAB N/A
  • MOB N/A
  • EPS
  • BCAB N/A
  • MOB N/A
  • Revenue
  • BCAB $11,000,000.00
  • MOB $3,180,565.00
  • Revenue This Year
  • BCAB N/A
  • MOB N/A
  • Revenue Next Year
  • BCAB N/A
  • MOB N/A
  • P/E Ratio
  • BCAB N/A
  • MOB N/A
  • Revenue Growth
  • BCAB N/A
  • MOB 44.98
  • 52 Week Low
  • BCAB $0.24
  • MOB $0.85
  • 52 Week High
  • BCAB $2.53
  • MOB $5.00
  • Technical
  • Relative Strength Index (RSI)
  • BCAB 42.24
  • MOB 59.08
  • Support Level
  • BCAB $0.36
  • MOB $2.41
  • Resistance Level
  • BCAB $0.43
  • MOB $3.03
  • Average True Range (ATR)
  • BCAB 0.04
  • MOB 0.41
  • MACD
  • BCAB -0.00
  • MOB -0.03
  • Stochastic Oscillator
  • BCAB 16.00
  • MOB 48.21

About BCAB BioAtla Inc.

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.

About MOB Mobilicom Limited

Mobilicom Ltd is a provider of cybersecurity and smart solutions for drones, robotics & autonomous platforms. As a high-tech company, it designs, develops, and delivers smart solutions targeting global drone, robotics, and autonomous system manufacturers. Its products include OS3 Platform Software, ICE Cybersecurity Software, MCU Mesh Networking, SkyHopper Datalinks, Mobile Ground Control Stations and System Engineering Services.

Share on Social Networks: